Gene · 833
Papers4,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 4,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Non-signaling but all important: how the linker, hinge, and transmembrane domains in the CAR hold it all together. | Front Immunol | 2025 | 41221288 | PubTator, text mining | PubMed |
| Development of antigen multimers for detection and evaluation of CAR T cells. | Cancer Immunol Immunother | 2025 | 41128768 | PubTator, text mining | PubMed |
| Expanding the phenotype of CARS1 variants to include congenital hyperinsulinism. | BMC Med Genomics | 2025 | 41121266 | PubTator, text mining | PubMed |
| The influence of ferroptosis-associated gene HSPA5 on the prognosis and immune evasion of lung adenocarcinoma. | Discov Oncol | 2025 | 41085902 | PubTator, text mining | PubMed |
| Differential item functioning in the children autism rating scale first edition in children with autism spectrum disorder based on a machine learning approach. | Front Neurol | 2025 | 41018196 | PubTator, text mining | PubMed |
| Distinct cell state ecosystems for nodular lymphocyte-predominant Hodgkin lymphoma. | Nat Commun | 2025 | 41006203 | PubTator, text mining | PubMed |
| Enhancement of lentiviral vectors gene delivery against VEGFR2 expressing cells by co-display of the binding and fusogenic moieties: a two molecules targeting approach. | Virol J | 2025 | 40993690 | PubTator, text mining | PubMed |
| Mechanisms of Resistance to CAR T-Cells and How to Overcome Them. | Methods Protoc | 2025 | 40981226 | PubTator, text mining | PubMed |
| CAR binding efficacy and off-target interactions for common CAR detection reagents. | J Immunol Methods | 2025 | 40885464 | PubTator, text mining | PubMed |
| Exploring the role of ferroptosis in esophageal cancer: mechanisms and therapeutic implications. | Cell Death Discov | 2025 | 40855044 | PubTator, text mining | PubMed |
| The expression of transmembrane channel-like 5 in gastric cancer and its impact on tumor progression. | Sci Rep | 2025 | 40851023 | PubTator, text mining | PubMed |
| Advancements and challenges in CAR-T cell therapy for solid tumors: A comprehensive review of antigen targets, strategies, and future directions. | Cancer Cell Int | 2025 | 40849468 | PubTator, text mining | PubMed |
| Novel combination of irreversible electroporation and allogenic chimeric antigen receptor (CAR) T-cell therapy synergizes therapeutic outcomes in a preclinical human pancreatic cancer mouse model. | bioRxiv | 2025 | 40832328 | PubTator, text mining | PubMed |
| Machine learning based screening of biomarkers associated with cell death and immunosuppression of multiple life stages sepsis populations. | Sci Rep | 2025 | 40830558 | PubTator, text mining | PubMed |
| The ATF4-glutamine axis: a central node in cancer metabolism, stress adaptation, and therapeutic targeting. | Cell Death Discov | 2025 | 40830338 | PubTator, text mining | PubMed |
| Dual targeting of BCMA and SLAMF7 with the CARtein system: chimeric antigen receptors with intein-mediated splicing elicit specific T cell activation against multiple myeloma. | Front Immunol | 2025 | 40821776 | PubTator, text mining | PubMed |
| Machine Learning-Based Integration of Single-Cell and Bulk Transcriptome Reveals Coagulation Signature and Phenotypic Heterogeneity in Hepatocellular Carcinoma. | IET Syst Biol | 2025 | 40820328 | PubTator, text mining | PubMed |
| Correction: Expression of anti-amyloid CARs in microglia promotes efficient and selective phagocytosis of Aβ1‒42. | Gene Ther | 2025 | 40817387 | PubTator, text mining | PubMed |
| Targeting degradation of IKZF1 and IKZF3 through modulation of the E3 ligase substrates in the context of cellular therapies for multiple myeloma. | Biomark Res | 2025 | 40817326 | PubTator, text mining | PubMed |
| IL-7 armed binary CAR T cell strategy to augment potency against solid tumors. | Front Immunol | 2025 | 40808942 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/papers?page=3